+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dementia Drug"

From
From
Lewy Body Dementia Treatment Market Report 2025 - Product Thumbnail Image

Lewy Body Dementia Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Dementia Treatment Market - Product Thumbnail Image

Dementia Treatment Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
Lewy Body Dementia (LBD) - Pipeline Insight, 2024 - Product Thumbnail Image

Lewy Body Dementia (LBD) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Dementia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Dementia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 913 Pages
  • Global
From
Loading Indicator

The Dementia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Dementia drugs are used to treat the cognitive decline associated with Alzheimer's disease, vascular dementia, and other forms of dementia. These drugs are typically prescribed to improve memory, thinking, and behavior, as well as to slow the progression of the disease. Common dementia drugs include cholinesterase inhibitors, memantine, and glutamate modulators. Some companies in the Dementia Drug market include Pfizer, Novartis, Merck, and Eli Lilly. Other companies include Biogen, AstraZeneca, and Johnson & Johnson. Show Less Read more